• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

PRELID1 Polyclonal antibody

PRELID1 Polyclonal Antibody for IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 10877-1-AP

Synonyms

CGI 106, PRELI, PRELI domain containing 1, PRELID1, PX19, Px19 like protein, SBBI12

Validation Data Gallery

Filter:
  • Immunohistochemistry (IHC) staining of human breast cancer tissue using PRELID1 Polyclonal antibody (10877-1-AP)

    IHC staining of human breast cancer using 10877-1-AP

    Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 10877-1-AP (PRELID1 Antibody) at dilution of 1:200 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human breast cancer tissue using PRELID1 Polyclonal antibody (10877-1-AP)

    IHC staining of human breast cancer using 10877-1-AP

    Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 10877-1-AP (PRELID1 Antibody) at dilution of 1:200 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using PRELID1 Polyclonal antibody (10877-1-AP)

    IHC staining of human liver cancer using 10877-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 10877-1-AP (PRELID1 Antibody) at dilution of 1:200 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using PRELID1 Polyclonal antibody (10877-1-AP)

    IHC staining of human liver cancer using 10877-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 10877-1-AP (PRELID1 Antibody) at dilution of 1:200 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human colon cancer tissue using PRELID1 Polyclonal antibody (10877-1-AP)

    IHC staining of human colon cancer using 10877-1-AP

    Immunohistochemical analysis of paraffin-embedded human colon cancer using 10877-1-AP (PRELID1 antibody) at dilution of 1:10 (under 25x lens).

☆大好評トライアルサイズ ¥20,000～！ >>> 一次抗体特別価格キャンペーン開催中！

Tested Applications

Positive IHC detected inhuman breast cancer tissue, human colon cancer tissue, human liver cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 1 publications below

Product Information

10877-1-AP targets PRELID1 in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen PRELID1 fusion protein Ag1037 相同性解析による交差性が予測される生物種
Full Name PRELI domain containing 1
Calculated molecular weight 25 kDa
GenBank accession numberBC008307
Gene symbol PRELID1
Gene ID (NCBI) 27166
RRIDAB_2168787
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
IHC protocol for PRELID1 antibody 10877-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Onco Targets Ther

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.

Authors - Dafeng Xu
View Article